BACKGROUND: Levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) are elevated in chronic kidney disease (CKD) and may contribute to vascular complications. In this study we tested the hypothesis that elevated ADMA can be reduced in obese CKD patients by long-term administration of a low-protein diet supplemented with keto-amino acids. PATIENTS AND METHODS: In a long-term prospective double-blind placebo-controlled randomized trial, we evaluated for a period of 36 months a total of 111 CKD patients (54 men, 57 women) aged 22-76 years with obesity (BMI >or= 30 kg/m(2)) and an inulin clearance rate (C(in)) of 22-40 ml/min/1.73 m(2). All patients were on a low-protein diet containing 0.6 g protein/kg BW per day and 120-125 kJ/kg BW per day. The diet was randomly supplemented with keto-amino acids at a dosage of 100 mg/kg BW per day (66 patients, Group I); 65 patients received placebo (Group II). RESULTS: During the study period, the glomerular filtration rate decreased slightly in Group I (C(in) from 32.4 +/- 12.6 to 29.8 +/- 8.6 ml/min/1.73 m(2)) and more markedly in Group II (from 33.2 +/- 12.6 to 23.2 +/- 98.4 ml/min/1.73 m(2), P < 0.01). BMI decreased significantly in Group I (from 32.0 +/- 3.3 to 26.1 +/- 4.0 kg/m(2), P < 0.01) and was linked to reduced volume of visceral fat measured by MRI (P < 0.01). Reduction of BMI in Group II was not significant. In Group I, there was a significant decrease in the plasma level of ADMA (from 2.5 +/- 0.5 to 1.3 +/- 0.4 micromol/l, P < 0.01), but ADMA remained unchanged in Group II. A further remarkable finding in Group I was reduction in the plasma concentration of pentosidine (from 480 +/- 170 to 320 +/- 120 microg/l, P < 0.01) and decrease of proteinuria (from 3.8 +/- 2.24 to 1.6 +/- 1.0 g/24 h, P < 0.02). Plasma adiponectin rose in Group I (P < 0.01). Analysis of the lipid spectrum revealed a mild but significant decrease in total cholesterol and LPD-cholesterol (P < 0.02), more pronounced in Group I. There was also a decrease in plasma triglycerides in Group I (from 3.9 +/- 1.6 down to 2.2 +/- 0.6 mmol/l, P < 0.01) and a decrease in glycated hemoglobin (from 7.2 +/- 1.4% to 4.2 +/- 0.8%, P < 0.02). CONCLUSION: Compared with the placebo group, long term co-administration of a low-protein diet and keto-amino acids in CKD patients with obesity led to decreases of ADMA, visceral body fat and proteinuria. Concomitant decreases of glycated hemoglobin, LDL-cholesterol and pentosidine may also contribute to the delay in progression of renal failure.

Department of Nephrology Transplant Center Institute for Clinical and Experimental Medicine Prague Czech Republic

Zobrazit více v PubMed

Curr Opin Lipidol. 2002 Feb;13(1):51-9 PubMed

Curr Opin Nephrol Hypertens. 2006 May;15(3):314-20 PubMed

J Am Soc Nephrol. 2002 Jan;13(1):134-41 PubMed

Diabetes Care. 2003 Jun;26(6):1673-8 PubMed

Wien Klin Wochenschr. 2005 Dec;117(23-24):816-20 PubMed

Nephrol Dial Transplant. 2002 Feb;17(2):191-5 PubMed

Kidney Int Suppl. 2003 May;(84):S65-8 PubMed

Atheroscler Suppl. 2003 Dec;4(4):23-8 PubMed

J Am Soc Nephrol. 2003 Mar;14(3):728-31 PubMed

Kidney Int. 2006 Aug;70(4):781-7 PubMed

Metabolism. 2004 Aug;53(8):1072-5 PubMed

Vnitr Lek. 2006 Jun;52(6):571-6 PubMed

J Nephrol. 2007 Sep-Oct;20(5):554-9 PubMed

J Ren Nutr. 2005 Jan;15(1):131-6 PubMed

Wien Klin Wochenschr. 2000 Oct 27;112(20):876-81 PubMed

J Clin Endocrinol Metab. 2004 Dec;89(12 ):6277-81 PubMed

Physiol Res. 2004;53(2):123-9 PubMed

Circulation. 1999 Jun 22;99(24):3092-5 PubMed

Kidney Int. 2004 Jan;65(1):274-81 PubMed

J Clin Endocrinol Metab. 2006 May;91(5):1896-900 PubMed

J Clin Invest. 2003 Dec;112(12):1796-808 PubMed

Acta Diabetol. 2005 Apr;42 Suppl 1:S3-8 PubMed

Kidney Int Suppl. 1989 Nov;27:S231-5 PubMed

Circulation. 1999 Mar 9;99(9):1141-6 PubMed

Jpn Circ J. 2001 Sep;65(9):775-8 PubMed

J Am Soc Nephrol. 2003 Jun;14 (6):1614-22 PubMed

Nephrol Dial Transplant. 2001 Sep;16(9):1742-5 PubMed

J Ren Nutr. 2005 Jan;15(1):166-72 PubMed

Physiol Res. 2004;53(2):229-34 PubMed

Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S26-30 PubMed

J Am Soc Nephrol. 2005 Aug;16(8):2456-61 PubMed

Metabolism. 2005 Mar;54(3):345-50 PubMed

Nephron. 2002 May;91(1):64-73 PubMed

Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease